Optical Internal Urethrotomy — Technique, Patient Selection, and Recovery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Optical internal urethrotomy (OIU), also known as direct vision internal urethrotomy (DVIU) or the Sachse urethrotomy, is an endoscopic procedure in which a urethral stricture is incised under direct optical visualisation using a cold (unheated) knife blade or laser fibre delivered through a rigid or semi-rigid urethrotome. The procedure restores the urethral lumen by cutting through the cicatricial fibrotic tissue (spongiofibrosis) that has narrowed the urethra, thereby improving urinary flow and relieving obstructive lower urinary tract symptoms.

Urethral stricture disease arises when the normal elastic urethral epithelium and underlying corpus spongiosum are replaced by inelastic scar tissue. This spongiofibrosis — the hallmark pathology of stricture disease — may be superficial and limited to the mucosal layer (amenable to endoscopic incision) or deep and transmural (indicating dense fibrosis likely to recur early after any endoscopic treatment). The depth and extent of spongiofibrosis, assessed by urethral ultrasound or high-resolution MRI, is a key predictor of optical internal urethrotomy outcomes and guides decisions between endoscopic and open reconstructive approaches.

First systematically described by Sachse in 1974, optical internal urethrotomy became the dominant treatment for urethral strictures through the 1980s and 1990s due to its simplicity, safety, and minimal invasiveness compared to open urethroplasty. Contemporary urological practice has substantially refined the indications for optical internal urethrotomy following accumulating evidence demonstrating high long-term recurrence rates — particularly after failed first procedures — and the superior durability of urethroplasty (open urethral reconstruction) for recurrent, long, or complex strictures.

Current guidance from the European Association of Urology (EAU) and American Urological Association (AUA) positions optical internal urethrotomy as the preferred first-line approach for short (<1.5 cm), primary, bulbar urethral strictures in patients who understand the recurrence risk and are committed to structured follow-up. For all other stricture presentations — penile location, length greater than 2 cm, prior failed endoscopic treatment, lichen sclerosus, or complex multi-site disease — urethroplasty should be offered as the superior definitive treatment.

Urethral stricture disease in males is a progressive fibrotic condition caused by damage to the urethral epithelium and underlying corpus spongiosum from inflammation, infection, trauma, or instrumentation. The scarring process narrows the urethral lumen, creating a flow-limiting obstruction with a spectrum of clinical consequences depending on stricture severity and duration.

Pathological basis — spongiofibrosis: The characteristic histopathological feature of urethral stricture is replacement of the normal elastic corpus spongiosum with dense, avascular collagen. This spongiofibrosis is graded by depth: superficial (limited to the submucosa), intermediate (extending into the corpus spongiosum), or deep (transmural, reaching the outer fascial layers). Deeper spongiofibrosis is associated with higher recurrence rates after any endoscopic treatment and greater complexity of reconstruction at urethroplasty.

Common aetiologies:

• Idiopathic / prior gonorrhoeal urethritis: Most common cause in many series; many historically attributed as “idiopathic” likely represent incompletely treated gonorrhoea causing bulbar strictures.
• Lichen sclerosus (balanitis xerotica obliterans, BXO): Progressive inflammatory skin disease causing pan-urethral involvement typically beginning at the meatus. Optical internal urethrotomy is not indicated — disease invariably recurs without treatment of the underlying condition; buccal mucosal graft urethroplasty with penile skin excision is the standard.
• Post-traumatic: Straddle (perineal) injury to the bulbar urethra, pelvic fracture posterior urethral injury.
• Iatrogenic: Post-catheterisation strictures (meatal, penile), post-TURP (bladder neck or membranous), post-brachytherapy.
• Hypospadias repair complications: Complex often pan-urethral strictures requiring specialised reconstructive expertise.

Clinical impact of stricture disease: Patients experience a constellation of obstructive LUTS including poor urinary stream (characteristic “plateau-pattern” uroflowmetry), urinary hesitancy and straining, post-void dribbling, incomplete bladder emptying, and recurrent UTIs. Prolonged high-grade obstruction can cause bladder trabeculation, vesicoureteric reflux, hydronephrosis, and chronic kidney disease. Periurethral abscess, urethrocutaneous fistula, and urethral carcinoma are rare but serious complications of long-neglected stricture disease. Sexual dysfunction, including ejaculatory impairment and pelvic floor dysfunction, is common and frequently underreported.

The most important determinant of optical internal urethrotomy success is careful patient selection based on stricture characteristics, treatment history, and realistic patient expectations regarding recurrence. The procedure should be offered with transparent discussion of its long-term success rates and the availability of superior definitive alternatives.

Pre-procedure diagnostic evaluation:

• Flexible cystoscopy / urethroscopy: The initial investigative step in stricture assessment. A flexible cystoscope or semi-rigid urethroscope is passed transurethrally to directly visualise the stricture: its location, apparent calibre, mucosal appearance, and whether the scope can negotiate the stricture. Flexible cystoscopy defines stricture accessibility and guides retrograde urethrogram planning. If diagnostic cystoscopy is immediately followed by therapeutic DVIU in the same anaesthetic episode, no separate diagnostic visit is required.
• Retrograde urethrogram (RUG) and voiding cystourethrogram (VCUG): Fluoroscopic contrast imaging defines stricture length, location, number, and the degree of proximal urethral involvement. RUG fills the urethra from the meatus; VCUG fills retrogradely via suprapubic catheter or during voiding post bladder filling. The two studies together provide a complete map of the stricture and are essential for surgical planning.
• Uroflowmetry with post-void residual (PVR) ultrasound: Objective assessment of peak flow rate (Qmax) and bladder emptying. Stricture disease produces a characteristic plateau-shaped flow curve with low Qmax (typically <10 mL/s). PVR quantifies the degree of bladder outlet obstruction and bladder decompensation.
• Urethral ultrasound: Increasingly used to grade spongiofibrosis depth and circumferential extent. High-frequency perineal ultrasound accurately assesses the tissue depth of fibrosis, complementing fluoroscopic length measurements and improving patient selection and prognostic counselling.
• Urine microscopy and culture: Active urinary infection is a contraindication to DVIU and must be treated with appropriate antibiotics before proceeding.

Optimal vs poor candidates — summary criteria: Optimal candidates have a primary, short (<1.5 cm), single-site, bulbar, non-BXO stricture with superficial spongiofibrosis and no prior endoscopic treatment. Poor candidates include those with prior failed DVIU, penile or meatal location, BXO, long or pan-urethral stricture, dense spongiofibrosis, fistula, or periurethral abscess. Shared decision-making with full disclosure of recurrence rates and the option of urethroplasty is essential.

Optical internal urethrotomy is performed as a day case or short-stay procedure under general, spinal, or local anaesthesia with sedation. The patient is placed in the dorsal lithotomy position. The bladder is first assessed by cystoscopy to exclude concomitant bladder pathology before the urethrotome is introduced for the therapeutic incision.

Step 1: Cystoscopic Assessment

A 0-degree or 30-degree rigid cystoscope is passed transurethrally to assess the bladder. If flexible cystoscopy was performed as a prior diagnostic procedure, this rigid step may be combined with the therapeutic DVIU in the same episode. The urethrotome is then introduced along the urethra under direct vision until the proximal face of the stricture is reached and clearly identified.

Step 2: Cold Knife (Sachse) Urethrotomy Technique

The Sachse optical urethrotome houses an optical system (0-degree or 12-degree telescope) and a retractable cold knife blade on a forward-mounted rail mechanism. With the stricture visualised in the centre of the optical field, the knife is advanced on the rail and cuts through the scar tissue in the 12 o'clock position (superior aspect of the urethra) to avoid the ventral vasculature and neurovascular structures. The incision is deepened until healthy, vascular, non-scarred tissue is reached proximal to the stricture and the instrument passes freely into the wider, healthy proximal urethra. Additional radial incisions at the 5 and 7 o'clock positions may be made for dense circumferential strictures. The goal is to incise through all layers of scar until bleeding healthy tissue is reached — an endpoint confirmed by visual inspection of the incision margin.

Step 3: Laser Urethrotomy Technique

A 365 or 550 micrometre holmium:YAG laser fibre, or a thulium fibre laser (TFL) fibre, is introduced through the working channel of a rigid or flexible urethroscope. Laser energy is delivered in short pulses to ablate and incise through the stricture tissue at the 12 o'clock position with minimal collateral thermal damage to surrounding tissue (<0.5 mm with Ho:YAG). Laser offers improved haemostasis compared to cold knife and allows use of flexible urethroscopes in patients where rigid instrumentation passage is challenging. TFL at 1,940 nm provides a continuous-wave cutting mode with excellent haemostasis and emerging evidence of precision advantages for complex strictures.

Step 4: Catheter Placement and Antibiotic Protocol

After the incision is completed and haemostasis confirmed, a 16–18 Fr urethral catheter is passed into the bladder under vision and secured. Catheter dwell time varies by protocol: 24–48 hours for simple primary strictures, 5–7 days for dense or complex incisions. Perioperative antibiotic prophylaxis (fluoroquinolone or cephalosporin) is administered at induction and continued while the catheter remains in situ. At catheter removal, uroflowmetry confirms adequate Qmax improvement (target >15 mL/s).

Optical internal urethrotomy provides rapid, measurable improvement in urinary flow and obstructive symptom relief in the immediate post-procedural period. Understanding expected Qmax gains and the timeframe for improvement helps patients set realistic expectations and enables objective monitoring of treatment response.

Quantitative flow improvement: Peak urinary flow rate (Qmax) is the primary objective outcome measure for urethral stricture treatment. Before optical internal urethrotomy, patients with clinically significant stricture disease typically have Qmax measurements of 4–9 mL/s with a characteristically flat, plateau-shaped uroflow curve. Following successful DVIU:

• Qmax typically improves by 10–15 mL/s above baseline in the immediate post-catheter-removal period
• A post-procedure Qmax of 15–20 mL/s with restoration of a normal bell-shaped uroflow curve indicates technically successful urethral widening
• Post-void residual (PVR) typically falls to <50 mL in uncomplicated cases

Symptomatic improvement: Voiding difficulty, urinary hesitancy, poor stream, straining to void, sensation of incomplete emptying, and post-void dribbling resolve promptly in the majority of patients following urethral widening. International Prostate Symptom Score (IPSS) typically falls by 8–12 points after successful DVIU. Quality-of-life subscores, urgency, and frequency symptoms also improve as bladder outlet obstruction is relieved.

Minimal invasiveness: DVIU requires no skin incision, creates no external wound, and is associated with a short recovery period. Most patients tolerate the procedure well and return to desk-based work within 2–5 days of catheter removal. There is no convalescence period comparable to open urethroplasty (which requires 4–6 weeks of restricted activity).

No compromise of future definitive treatment: An appropriately performed DVIU does not impair the subsequent success of urethroplasty should stricture recurrence occur. Early escalation to urethroplasty after DVIU failure is recommended rather than repeated endoscopic attempts that progressively worsen spongiofibrosis and reduce future reconstructive options.

The principal limitation of optical internal urethrotomy is not safety — which is generally excellent — but durability. Understanding the biology of scar re-formation and the risk factors that predict early recurrence is essential for counselling patients and planning post-procedure management.

Biology of stricture recurrence after DVIU: The incision made during optical internal urethrotomy creates a healing wound within fibrotic spongiosum. If healing follows a fibrotic rather than a regenerative pathway — driven by the depth of pre-existing spongiofibrosis, the blood supply to the cut tissue, and the inflammatory environment — progressive scar re-formation begins within weeks and can produce a flow-limiting re-stricture within 3–12 months. Deeper, denser spongiofibrosis is the strongest predictor of early recurrence, as the wound bed lacks healthy, well-vascularised tissue capable of regenerative healing.

Recurrence rates by scenario:

• Primary short bulbar stricture: approximately 40–50% recurrence within 2 years, rising to 50–60% by 5 years even in ideal candidates
• Repeat DVIU after one failure: over 60–70% recurrence within 2 years; approximately 88% recurrence by 5 years (TURNS trial)
• Penile urethral stricture: recurrence rates exceed 80% within 12–24 months after any endoscopic treatment

Peri-procedural complications:

• Haematuria and dysuria: Universal immediately after the procedure; typically resolves within 5–10 days of catheter removal
• Urinary tract infection: 5–15% incidence; mitigated by pre-operative urine sterilisation and peri-operative antibiotic prophylaxis
• Urethral false passage / perforation: Uncommon with cold knife in experienced hands; managed conservatively with prolonged catheterisation
• Bleeding requiring intervention: Rare (<1%); laser techniques have slightly superior haemostatic control

Long-term risks of repeated DVIU: Repeated endoscopic incision and catheterisation cycles worsen spongiofibrosis, progressively reducing the success rate of each subsequent procedure and potentially increasing the technical complexity and graft length required at eventual urethroplasty. Most urethral reconstruction experts recommend no more than one or two DVIU attempts before offering definitive urethroplasty.

Post-DVIU management focuses on monitoring for recurrence, maintaining urethral patency during the healing phase, and timely escalation to urethroplasty when endoscopic treatment has failed or is unlikely to succeed with further attempts.

Catheter removal and initial recovery: The urethral catheter is typically removed at 24–72 hours post-procedure with uroflowmetry at removal confirming adequate Qmax (>15 mL/s). Mild haematuria and urethral burning are expected for 5–10 days. Oral hydration (>2 litres/day), avoidance of strenuous activity, and avoidance of sexual intercourse for 2–4 weeks are standard post-procedure instructions.

Clean intermittent catheterisation (CIC) — a maintenance strategy: Where adopted by the treating centre, a self-catheterisation protocol is initiated before or shortly after discharge. The rationale is that regular catheter passage maintains urethral calibre during the early healing phase and provides an objective early warning of stricture recurrence (inability to pass the catheter or acute drop in Qmax). A typical reducing schedule used in clinical practice:

• Week 1–4: Daily CIC with 14–16 Fr catheter
• Month 2: Every other day
• Months 3–4: Three times weekly
• Months 5–6: Twice weekly
• Months 7–12: Once weekly

The catheter and a sterile lubricant (hydrophilic single-use catheters are preferred) are prescribed on discharge with written instruction and a physiotherapy or urology nurse teaching session before leaving hospital.

Structured uroflowmetry surveillance: Objective uroflowmetry is performed at 3, 6, and 12 months post-DVIU, then annually for at least 5 years. A Qmax <12 mL/s or recurrence of obstructive LUTS at any follow-up visit triggers flexible cystoscopy or repeat urethrogram to confirm recurrence. Patients should be given clear written guidance on symptoms to report promptly (acute retention, progressive flow deterioration, new recurrent UTI) between scheduled review appointments.

Decision algorithm — when to escalate to urethroplasty:

• Recurrence within 12 months of primary DVIU: refer for urethroplasty assessment
• Any recurrence after a second DVIU: strong indication for definitive urethroplasty
• Progressive stricture despite CIC programme: refer for reconstruction
• Stricture at penile or meatal location: urethroplasty from the outset
• Lichen sclerosus identified on biopsy: urethroplasty with non-genital grafting essential

Optical internal urethrotomy is among the most cost-effective initial surgical options for urethral stricture disease, primarily because of its short operative time, day-surgery setting, and minimal consumable requirements (particularly with cold knife technique). However, when the cumulative cost of multiple DVIU procedures and surveillance visits over 5–10 years is calculated, the cost-effectiveness advantage over single-procedure urethroplasty diminishes considerably for patients with high-recurrence-risk strictures.

Procedure cost determinants:

• Anaesthesia type: Local anaesthesia with sedation (used in some centres for cooperative patients) substantially reduces costs compared to general or spinal anaesthesia with full anaesthesia team involvement.
• Instrumentation: Cold knife Sachse urethrotome — reusable, low per-case consumable cost. Laser DVIU — higher capital equipment cost for the laser platform; single-use disposable fibres add to per-case consumable cost. Flexible urethroscopes (for laser) require sterilisation or are single-use, adding further to per-case cost.
• Setting: Day-surgery theatre is the most common and cost-efficient setting. Overnight admission approximately doubles facility costs.
• Post-procedure CIC: Single-use hydrophilic catheters for a 12-month programme represent a recurring cost that should be included in total management cost estimates.
• Surveillance: Uroflowmetry visits and urethrogram imaging for recurrence detection at 3, 6, and 12 months (then annually) represent ongoing expenditure.

Cumulative cost of recurrence: Each stricture recurrence requiring repeat DVIU adds the full procedure cost again. Health economic modelling comparing DVIU versus urethroplasty over 10 years consistently favours urethroplasty for strictures with a high probability of early recurrence, particularly when patient time costs (repeated hospital visits, time off work) are included.

International access: In lower-income healthcare systems, optical internal urethrotomy is often the only treatment realistically available. Urethroplasty requires experienced urethral reconstructive surgeons, longer operating time, and theatre infrastructure. At internationally accredited urology centres in India, Thailand, and Turkey, both DVIU and urethroplasty are available at 40–70% lower cost than in the USA or UK, with outcomes comparable to leading Western centres for experienced surgeons.

Optical internal urethrotomy occupies a defined, limited niche within the broader management algorithm for urethral stricture disease. The algorithm should be followed systematically to avoid under-treating patients who are suitable for definitive cure by urethroplasty or over-treating with repeated DVIU procedures that progressively worsen outcomes.

Urethral dilation: Gentle urethral dilation using metal sounds (van Buren sounds) or balloon dilators widens the stricture by compressive distension rather than incision. Outcomes are marginally inferior to DVIU and recurrence occurs at similar or earlier time points. Dilation is most appropriate for office-based maintenance in patients managed long-term with periodic dilation — a cohort that includes elderly or medically unfit patients not suitable for surgery. Self-dilation at home (patient-performed with a catheter or dilator) is an alternative to clinician-performed dilation for maintenance patency in selected cooperative patients.

Clean intermittent self-catheterisation (CIC) alone: For patients with significant comorbidity precluding any surgical intervention, regular self-catheterisation maintains urethral patency without addressing the underlying fibrosis. CIC programmes are well tolerated by most patients who receive adequate initial instruction and ongoing support.

Urethroplasty — when it supersedes DVIU:

• Excision and primary anastomosis (EPA): Ideal for short (<2 cm) bulbar strictures with normal proximal and distal urethra. The fibrotic segment is excised and healthy ends reanastomosed. 5-year stricture-free rates of 90–95%. Minimal morbidity; perineal wound heals in 4–6 weeks.
• Buccal mucosal graft (BMG) urethroplasty: For longer bulbar or penile strictures where primary anastomosis would create tension or penile chordee. Inner cheek mucosa is harvested and inlaid as a dorsal, ventral, or lateral onlay graft. 5-year success rates of 80–90%. BMG is not suitable for pan-urethral lichen sclerosus — substitute penile or non-genital tissue grafts are used.
• Staged urethroplasty (two-stage Johanson): Reserved for complex pan-urethral strictures, failed prior graft urethroplasty, or hypospadias cripples. The first stage marsupialisies the urethra to the perineal skin; the second stage tubularises the neo-urethra at 6–12 months.

Permanent urethral stents: No longer recommended. Urolume stents have poor long-term outcomes due to epithelial ingrowth, hyperplasia, stent migration, and extreme technical difficulty of removal when they fail. Removed from routine practice guidance by EAU and AUA.

Suprapubic catheterisation: Emergency measure for acute urinary retention from complete urethral obstruction. Allows bladder decompression and elective definitive planning without the risks of forced retrograde catheterisation through a tight stricture.